Journal profile · HEMATOLOGYPATHOLOGY-PATHOLOGY
Journal of Hematopathology
ISSN 1868-9256 · eISSN 1865-5785 · Springer Berlin Heidelberg · NETHERLANDS · 4 issues per year · Founded 2008
Journal of Hematopathology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.03; hybrid open access; APC about USD 3,890; median 74 days to acceptance (77 articles, last 24 months); 61 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Hematopathology is published by Springer Berlin Heidelberg and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and Viral-associated cancers and disorders, together about 42.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Hematopathology aims at providing pathologists with a special interest in hematopathology with information needed to perform high-quality diagnostic pathology of hematopoietic and lymphoid diseases in lymphoid tissues, bone marrow and peripheral blood. To this end the journal publishes reviews, editorials, comments, original papers, guidelines and protocols, papers on ancillary techniques, case reports, and images on all topics within the subspecialty of diagnostic hematopathology. The journal is a useful reference point for all pathologists with an interest in hematopathology. Molecular biologists involved in the expanding field of molecular diagnostics and research on lymphomas and leukemia benefit from the journal, too. Furthermore, the journal is of major interest for hematologists dealing with patients suffering from lymphomas, leukemias, and other benign and malignant hematopoietic and lymphoid diseases. The journal maintains an international character among its editors, editorial board and authorship, as the field of hematopathology has considerable geographical variations in incidence of diseases. This is not only locally relevant, but due to globalization, relevant for all those involved in the management of patients with hematolymphoid patients.
From the journal's Aims & Scope
Research area (LetPub): HEMATOLOGYPATHOLOGY-PATHOLOGY
Editor-in-chief Nathanael G. BaileyPublisher website
Editorial board by country: none in mainland China; most named United States 23, Germany 5, Netherlands 2, Switzerland 2, Hong Kong, China 1 (41 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lymphoma Diagnosis and TreatmentMedicine20.6%
- Chronic Lymphocytic Leukemia ResearchMedicine11.9%
- Viral-associated cancers and disordersMedicine10.5%
- Acute Myeloid Leukemia ResearchMedicine9.3%
- Hematological disorders and diagnosticsMedicine4.3%
- Chronic Myeloid Leukemia TreatmentsMedicine4%
- Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine4%
- CNS Lymphoma Diagnosis and TreatmentMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.03LetPub ·
- Impact factor (publisher) 2025
- 1Publisher website ·
- 5-year impact factor (publisher) 2025
- 0.8Publisher website ·
- CiteScore 2026-06
- 0.7LetPub ·
- SJR 2026-06
- 0.23LetPub ·
- SNIP 2026-06
- 0.39LetPub ·
- h-index
- 15LetPub ·
- h-index
- 25OpenAlex ·
- i10-index
- 83OpenAlex ·
- 2-year mean citedness
- 0.72OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 25%LetPub ·
Volume
- Articles per year
- 51LetPub ·
- Downloads per year (publisher) 2025
- 283,700Publisher website ·
Articles by year OpenAlex count · 732 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 59 | 20 | 5 |
| 2025 | 61 | 15 | 40 |
| 2024 | 45 | 44 | 74 |
| 2023 | 46 | 45 | 84 |
| 2022 | 49 | 48 | 86 |
| 2021 | 52 | 51 | 164 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
74 daysMedian, submission to acceptance · P25–P75 50 days – 105 days
- Acceptance to online
- median 11 days (77 articles)
- Submission to online
- median 88 days
- Sample
- 77 articles with submission and acceptance dates (72 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 9 daysPublisher website ·
- Peer review
- Single anonymous peer review, Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,890 / EUR 2,990 / GBP 2,590 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted17, with length limits
- case reportThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…main text ≤ 1,500 words · figures and tables ≤ 4
- case reportsCase reports specially written-up single cases which present original observations, new insights into pathogenetic mechanisms and/or information based on novel …Length not stated
- commentaryThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…Length not stated
- commentsComments can portray your view on a topical or controversial subject in the field, as well as anything of likely interest to the readers.Length not stated
- correspondenceThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…Length not stated
- editorialSingle-blind peer review This journal follows a single-blind reviewing procedure. This journal also publishes special/guest-edited issues. The peer review proce…Length not stated
- imagesOne to Two figures, which may be in the form of panels and include insets, should demonstrate a very good example of an unusual finding about which hematopathol…Length not stated
- letterThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…main text ≤ 1,000 words
- letters (correspondence)Letters may include commentaries about previous papers in the Journal of Hematopathology, on other matters of interest, reports on single cases, or negative fin…Length not stated
- meta-analysisThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…Length not stated
- original articleThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…main text ≤ 3,500 words · references ≤ 50
- original articlesOriginal articles should not exceed 3,500 words (not including the abstract, references and legends).Length not stated
- perspectiveThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…Length not stated
- reportsReports on meetings, symposia and conferences that deal with hematopathology should include both a statement of the purpose of the meeting and a summary of the …Length not stated
- reviewThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…Length not stated
- review articleThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…main text ≤ 4,500 words · figures and tables ≤ 5 · references ≤ 60
- review articlesReview articles for the Journal of Hematopathology should comprise no more than 4,500 words and 60 references.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Instructions for Complying with Ethical Standards
Please include a section called “Compliance with Ethical Standards” within your manuscript. Please always include each type of statement as well as the exact statement order and wording as described below for the five disclosure statements. Please always add all five statements, even if one or more are not applicable. 1. Funding (must be included): “This study was funded by X (grant number X)” In …
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
ORCID required for corresponding author Model summary
To find out more about publishing your work Open Access in Journal of Hematopathology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Single-blind peer review
Single-blind peer review Model summary
This journal follows a single-blind reviewing procedure. This journal also publishes special/guest-edited issues. The peer review process for these articles is the same as the peer review process of the journal in general. Additionally, if a guest editor authors an article in their issue/collection, they will not handle the peer review process. Submitted manuscripts will generally be reviewed by t…
Source ↗Publisher website ·- Plagiarism
Plagiarism screening via iThenticate Model summary
All manuscripts are evaluated via iThenticate for signs of any potential plagiarism.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Berlin Heidelberg
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- 4 issues per year
- Founded
- 2008
- ISSN
- 1868-9256
- Electronic ISSN
- 1865-5785
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Hematopathology
What CAS zone is Journal of Hematopathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Hematopathology is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology / Pathology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Hematopathology?
The latest impact factor listed by LetPub is 1.03; CiteScore 0.7, h-index 25.
How long does peer review take at Journal of Hematopathology?
Based on the dates recorded on 77 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 74 days (interquartile range 50–105 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Hematopathology?
According to the journal's author guidelines: Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Hematopathology based?
Of the 41 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (23), Germany (5) and Netherlands (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Hematopathology?
According to LetPub and DOAJ records, Journal of Hematopathology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE and Embase; that list has not been checked against each database.
Is Journal of Hematopathology open access, and what is the APC?
Journal of Hematopathology is a hybrid journal. For open-access publication: APC about USD 3,890.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .